Stock market announcements Archive - Page 21 of 24

Lifecare AS (LIFE-ME) – Exercise of options by primary insider – 06.08.2020

August 6, 2020
Lifecare’s Chief Scientific Officer, Prof. Dr. Dr. med Andreas Pfützner, hold share option rights both personally and through his company Islay Ventures GmbH. The share option agreement with Islay Ventures GmbH includes 521.321 share options in total and the exercise right is based on a detailed milestone plan. In addition, Islay Ventures GmbH hold 578.125 […]
Read more

Lifecare AS – Generalforsamling avholdt

June 26, 2020
Se vedlegg på www.newsweb.no
Read more

LIFE-ME: Aksjesalg Sterna Holding AS og Joacim Holter

June 17, 2020
Christian Saure har vært styreleder i Lifecare AS siden mai 2016. Han har varslet selskapet om at han ikke tar gjenvalg på årets generalforsamling og fratrer etter eget ønske pr 26.06.2020. I den forbindelse har Sterna Holding AS, et selskap 100 % eid av Christian Saure som er primærinnsider i Lifecare AS, den 15.06 og […]
Read more

Lifecares partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test …(Note: This headline has been truncated)

June 15, 2020
Lifecare’s partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test – plan for scaling capacities with production partners in USA and Europe and aim to bring test to the market in millions. The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has developed […]
Read more

LIFE-ME: Scientific breakthrough Lifecares partner Digital Diagnostics AG detects corona virus with rapid test

June 2, 2020
Scientific breakthrough: Lifecare’s partner Digital Diagnostics AG detects corona virus with rapid test, seeks FDA approval and plans to deliver units starting in July The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has successfully detected SARS-CoV-2 viruses using the revolutionary Cantisense™ technology at the Helmholtz Centre for […]
Read more

LIFE-ME: Sterna Holding AS aksjesalg 21.04.20

April 23, 2020
Sterna Holding AS, et selskap 100 % eid av Christian Saure som er styreformann og primærinnsider i Lifecare AS LIFE-ME) har 21. april og 22. april solgt 1.115.000 aksjer i Lifecare AS til kurs 3,4179. Salget skyldes en rebalansering av Sterna Holding AS sin investeringsportefølje. Etter salget eier Sterna Holding AS 2.235.000 aksjer i Lifecare […]
Read more

Lifecare and Digital Diagnostics – New 5 minute coronavirus test delivers clear results on infection

April 21, 2020
Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG, who is now developing a New 5 minute coronavirus test which delivers clear results on infection. Lifecare AS has previously established a joint venture with Digital Diagnostics AG in Germany. Digital Diagnostics (DD) will finance the remaining costs of completing the development of Lifecare’s […]
Read more

LIFE-ME: Share options for primary insiders extended exercise period.

April 1, 2020
The Board of Directors in Lifecare AS has extended the exercise period for: - 527.839 share options for Chief Operation Officer, Rune Frisvold; - 263.920 share options for Chief Scientific Officer, Andreas Pfützner, until April 1st, 2021. The options were issued December 2016 and has a strike price of NOK 0,40. This information is subject […]
Read more

Lifecare A/S (LIFE-ME) presented data at International Conference on Advanced Technology and Treatments fo …(Note: This headline has been truncated)

February 26, 2020
At the 13th International Conference on Advanced Technology and Treatments for Diabetes (ATTD) in Madrid, a key event for global scientist, leading healthcare professionals and life science decision makers, Lifecare A/S (LIFE-ME) presented a poster on its advances in the development of the Sencell Continuous Glucose monitor. The poster with the title “Miniaturization of an […]
Read more

LIFE-ME: Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology.

February 10, 2020
Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. 10.02.2020, Oslo Lifecare AS, a Norwegian life-science company, announced that they have filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. The purpose of this clinical pilot study is to explore the performance of the Sencell sensor technology […]
Read more